Some patients with side-effect concerns aiming to lessen their statin burden may prefer the treat-to-target approach, if they respond well to lesser-intensity statins, say researchers.

Related Keywords

South Korea , Seoul , Soult Ukpyolsi , Louisiana , United States , New Orleans , Texas , Houston , Baylor College Of Medicine , Pakistan , Karachi , Sindh , American , Salims Virani , Edward Lifesciences , Chong Kun Dang , American College Of Cardiology , National Institutes Of Health , Yonsei University College Of Medicine , Aga Khan University , Cardiovascular Research Center , Us Department Of Veterans Affairs , Office Of Research , Journal Of The American Medical Association , Scientific Session World Congress , Clinical Research , Medtronic , Myeong Ki Hong , Severance Hospital , Yonsei University College , American College , World Congress , American Medical , Medscape Cardiology , Baylor College , Graduate Studies , Viatris Korea , Samjin Pharmaceutical , Chong Kun Dang Pharmaceutical , Veterans Affairs , National Institutes , Jooma Family , Cardiology Scientific , Presented March , Lipids , Ipid Management , Statin , Lipid Lowering Drugs , Rug Lipid Lowering , Dyslipidemia , Cv , Ardiovascular , Patient Safety , Adverse Effects , Ide Effects , Clinical Guidelines , Uidelines , Low Ldl Cholesterol , Ypobetalipoproteinemia , Ow Low Density Lipoprotein Cholesterol , Acute Coronary Syndrome Acs , Cute Coronary Syndrome , Cs , Atherosclerotic Heart Disease , Therosclerotic Cardiovascular Diseas ,